Qube Research & Technologies LTD Reata Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $272,377 - $480,048	13,152 New	13,152 $400,000
Q1 2022 May 09, 2022	SELL	$24.12 - $39.6 $429,577 - $705,276	-17,810 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$25.61 - $110.96 $456,114 - $1.98 Million	17,810 New	17,810 $470,000
Q3 2020 Nov 12, 2020	SELL	$93.53 - $163.34 $3.53 Million - $6.16 Million	-37,720 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $4.76 Million - $6.66 Million	37,720 New	37,720 $5.89 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.